Lamotrigine Tablet
Product Images NDC 46708-276

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 46708-276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg 30's Hdpe Bottle Pack (Lamotrigine 100mg)

100 mg 30's Hdpe Bottle Pack (Lamotrigine 100mg)
Label for Lamotrigine Tablets USP 100 mg by Alembic Pharmaceuticals Limited. The image shows a rectangular label with dosage, lot, and expiration fields, storage instructions, and the note to dispense the accompanying Medication Guide. The package contains 30 oral tablets.*
FDA Label Image

150 mg 30's Hdpe Bottle Pack (Lamotrigine 150mg)

150 mg 30's Hdpe Bottle Pack (Lamotrigine 150mg)
Label for Lamotrigine Tablets, USP 150 mg oral tablets, manufactured by Alembic Pharmaceuticals Limited. The label indicates a quantity of 30 tablets per container and includes storage instructions, dispensing information, and a barcode. The label is primarily white with green accents and the Alembic logo.*
FDA Label Image

200 mg 30's Hdpe Bottle Pack (Lamotrigine 200mg)

200 mg 30's Hdpe Bottle Pack (Lamotrigine 200mg)
Packaging label for Lamotrigine Tablets, USP 200 mg oral tablets by Alembic Pharmaceuticals Limited. The label states NDC 46708-277-30 and includes dosage storage instructions, labeling for 30 tablets per container, and a note for pharmacists to dispense the accompanying medication guide. The label design features purple highlights and barcode information with manufacturer details from Gujarat, India.*
FDA Label Image

25 mg 30's Hdpe Bottle Pack (Lamotrigine 25mg)

25 mg 30's Hdpe Bottle Pack (Lamotrigine 25mg)
Lamotrigine Tablets, USP 25 mg oral tablets label by Alembic Pharmaceuticals Limited. The label includes the NDC 46708-274-30, packaging for 30 tablets, storage instructions, and a barcode. It specifies dispensing with the Medication Guide and indicates the product is prescription only.*
FDA Label Image

Description (Lamotrigine Descri)

Description (Lamotrigine Descri)
Packaging label displays four types of Lamotrigine tablets by Alembic Pharmaceuticals Limited: 25 mg white to off-white capsule-shaped tablets debossed with "L121"; 100 mg white to off-white round tablets debossed with "L122"; 150 mg white to off-white round tablets debossed with "L123"; and 200 mg white to off-white round tablets debossed with "L124".*
FDA Label Image

Figure 1 (Lamotrigine Figure1)

Figure 1 (Lamotrigine Figure1)
A Kaplan-Meier failure probability curve comparing Lamotrigine Tablets with a placebo over approximately 90 weeks. The vertical axis shows failure probability percentage, and the horizontal axis shows time in weeks. The graph includes censored data points for both groups.*
FDA Label Image

Figure 2 (Lamotrigine Figure2)

Figure 2 (Lamotrigine Figure2)
A survival curve chart showing failure probability (%) over weeks for Lamotrigine Tablets compared to Placebo. The x-axis represents weeks up to 80, and the y-axis shows failure probability from 0 to 100%. The chart includes censored data points and illustrates a higher failure probability for Placebo relative to Lamotrigine Tablets over time.*
FDA Label Image

Structure (Lamotrigine Str)

Structure (Lamotrigine Str)
Chemical structure of lamotrigine showing a triazine ring with chlorine atoms and amino substituents, corresponding to the drug lamotrigine's molecular arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.